Biomarin Pharmaceutical Inc’s filing revealed that its Officer Hubbard Cristin acquired Company’s shares for reported $17723.0 on May 02 ’25. In the deal valued at $64.92 per share,273 shares were bought.
Then, Burkhart Erin sold 1,295 shares, generating $92,618 in total proceeds. Upon selling the shares at $71.52, the GVP, Chief Accounting Officer now owns 16,955 shares.
Before that, Burkhart Erin bought 1,295 shares. Biomarin Pharmaceutical Inc shares valued at $92,618 were divested by the Officer at a price of $71.52 per share.
Oppenheimer upgraded its Biomarin Pharmaceutical Inc [BMRN] rating to an Outperform from a a Perform in a research note published recently. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid November with a ‘”an Outperform”‘ rating. William Blair also remained covering BMRN and has decreased its forecast on October 30, 2024 with a “Mkt perform” recommendation from previously “an Outperform” rating.
Price Performance Review of BMRN
On Monday, Biomarin Pharmaceutical Inc [NASDAQ:BMRN] saw its stock jump 0.05% to $62.06. Over the last five days, the stock has lost -1.46%. Biomarin Pharmaceutical Inc shares have fallen nearly -5.58% since the year began. Nevertheless, the stocks have fallen -25.53% over the past one year. While a 52-week high of $94.85 was reached on 03/07/25, a 52-week low of $52.93 was recorded on 04/09/25. SMA at 50 days reached $66.40, while 200 days put it at $70.74.
Levels Of Support And Resistance For BMRN Stock
The 24-hour chart illustrates a support level at 61.47, which if violated will result in even more drops to 60.88. On the upside, there is a resistance level at 62.74. A further resistance level may holdings at 63.42. The Relative Strength Index (RSI) on the 14-day chart is 46.14, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.63, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 45.14%. Stochastics %K at 65.86% indicates the stock is a holding.
